Cell-Free DNA at Diagnosis for Stage IV Non-Small Cell Lung Cancer: Costs, Time to Diagnosis and Clinical Relevance

SIMPLE SUMMARY: To obtain non-small-cell lung cancer (NSCLC) tissue, patients undergo burdensome procedures, such as needle biopsies or endoscopic or surgical procedures. Recent technological developments have enabled targeted sequencing using plasma. Next-generation sequencing (NGS) based on cfDNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Koole, Simone N., Vessies, Daan C. L., Schuurbiers, Milou M. F., Kramer, Astrid, Schouten, Robert D., Degeling, Koen, Bosch, Linda J. W., van den Heuvel, Michel M., van Harten, Wim H., van den Broek, Daan, Monkhorst, Kim, Retèl, Valesca P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997553/
https://www.ncbi.nlm.nih.gov/pubmed/35406555
http://dx.doi.org/10.3390/cancers14071783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997553/
https://www.ncbi.nlm.nih.gov/pubmed/35406555
http://dx.doi.org/10.3390/cancers14071783

Ejemplares similares